Connection
Stephanie Byrum to Neoadjuvant Therapy
This is a "connection" page, showing publications Stephanie Byrum has written about Neoadjuvant Therapy.
|
|
Connection Strength |
|
|
|
|
|
0.101 |
|
|
|
-
Loveland-Jones C, Gaughan J, Caudle A, Murphy B, Samiian L, Byrum S, Brill K, Germaine P, Zhang X, Yoon-Flannery K, Carter T, Lopez A, Gruner R, Fantazzio M, Kuerer H. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol. 2024 Apr; 50(4):108245.
Score: 0.054
-
Todorova VK, Byrum SD, Gies AJ, Haynie C, Smith H, Reyna NS, Makhoul I. Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer. Curr Oncol. 2022 01 28; 29(2):613-630.
Score: 0.047